Home › Heart Attack › New York
Heart Attack clinical trials in New York
7 studies for Heart Attack are looking for participants at sites in New York.
Cities in New York
Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk
- Mount Sinai Medical Center, New York
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 5, 2026 · NCT04774159Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
- Albany Medical College Committee of Research Involving Human Subjects, Albany
- SUNY Downstate Medical Center Brooklyn, Brooklyn
- Mattoo & Bhat Medical Associates, P.C., College Point
- and 3 more
RecruitingPhase 2/3
Ages 18 and older · All sexes · Updated Sep 21, 2026 · NCT05485961Implementation of IVS3 for Upper Limb Motor Recovery
- Weill Cornell Medicine, 525 E. 68th St, Baker Pavilion, F-2106, New York
Recruiting
Ages 18 and older · All sexes · Updated Sep 16, 2026 · NCT06483230OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
- Albany Medical College, Albany
- Basil Clinical, Inwood
- Rasai Research, Jackson Heights
- and 7 more
RecruitingPhase 3
Ages 50 to 105 · All sexes · Updated Aug 21, 2026 · NCT07136012TeleheartCR vs. Clinic-Based Cardiac Rehabilitation After Acute Coronary Syndrome
- Columbia University Irving Medical Center, New York
Recruiting
Ages 18 and older · All sexes · Updated Jun 3, 2026 · NCT07541014AI-Enabled Direct-from-ECG Ejection Fraction (EF) Severity Assessment Using COR ECG Wearable Monitor
- Mount Sinai Hospital, New York
RecruitingObservational studyHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Jun 1, 2026 · NCT06699056Heart Attack Research Program: Platelet Sub-Study (HARP)
- NYU Langone Medical Center, New York
RecruitingObservational studyHealthy volunteers welcome
Ages 21 to 99 · Women · Updated Apr 20, 2026 · NCT03022552From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.